U.S. Patient Engagement Solutions Market Growth, Size, Trends ,Analysis and Segment Forecast to 2034
U.S. Patient Engagement Solutions Market Growth, Size, Trends Analysis - By Type, By Delivery Type, By Functionality, By End User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: Oct-2025 | Report ID: HLCA25311 | Pages: 1 - 170 | Formats*: |
| Category : Healthcare | |||
U.S. Patient Engagement Solutions Market Introduction and Overview
According to SPER Market Research, the U.S. Patient Engagement Solutions Market is estimated to reach USD 47.86 billion by 2034 with a CAGR of 20.03%.
The report includes an in-depth analysis of the U.S. Patient Engagement Solutions Market, including market size and trends, product mix, Applications, and supplier analysis. The U.S. market for patient engagement solutions was valued at USD 7.71 billion in 2024 and is projected to experience a compound annual growth rate (CAGR) of 20.03% from 2025 to 2034. This anticipated growth is driven by several factors, including the rising incidence of chronic diseases, a transition towards value-based care, advancements in healthcare technology, and an increasing demand for personalized healthcare experiences.
By Type Insights
The AI-driven engagement segment generated the largest revenue share in 2024 and is expected to grow the fastest due to its capability to personalize patient care and improve interactions between patients and providers. AI tools, including chatbots and virtual assistants, enhance patient communication, automate scheduling, and offer personalized health advice. The remote patient monitoring (RPM) segment is set to expand rapidly because of the growing preference for at-home care, technological advancements in wearables, and the need for cost-effective health solutions. RPM allows patients to track vital signs from home, which reduces the need for hospital visits and enhances management of care, particularly as populations age and chronic conditions rise.
By Delivery Type Insights
The web/cloud-based segment was the leading market player in 2024, expected to grow at a fast rate due to the rise of telehealth, remote monitoring demand, and the shift towards value-based care. Cloud platforms support healthcare providers by offering real-time and secure access to patient data across devices. The on-premise segment has seen significant growth as well, driven by concerns over data security and the need for tailored solutions in healthcare environments.
By Functionality Insights
The enhanced communication segment also had a large revenue share in 2024. The adoption of AI solutions has led to a higher demand for improved communication capabilities, which allow healthcare organizations to interact efficiently with patients. The integration of advanced communication tools is expected to enhance patient engagement and satisfaction while also streamlining tasks like appointment scheduling. The patient education segment is projected to grow rapidly, fueled by the need for patients to access clear and actionable health information.
By End User Insights
The healthcare providers segment had the largest revenue share in 2024 as they manage most patients and act as the main contact for health issues. They are the biggest users of patient engagement solutions. The pharmaceutical companies segment is expected to grow the fastest, driven by the need for better patient adherence, lower treatment costs, and improved drug effectiveness. Pharma companies utilize engagement tools for patient education, support, and monitoring, responding to the demand for specialty drugs and regulatory pressure for better outcomes.
Regional Insights
The Northeast region has emerged as the leader in the U.S. Patient Engagement Solutions Market. This area boasts a robust healthcare infrastructure and a high density of prominent healthcare providers and technology firms. These elements, coupled with a strong emphasis on patient-centered care and the early adoption of digital health technologies, have positioned the Northeast at the forefront of developing and implementing patient engagement solutions. Furthermore, government initiatives and a culture that prioritizes technological advancements in healthcare have reinforced its leading status.
Market Competitive Landscape
Key players in the market are making significant investments in research and development to broaden their product offerings, which will further enhance the growth of the patient engagement solutions market. Additionally, market participants are engaging in various strategic initiatives to expand their presence, with notable developments including the introduction of new products, contractual agreements, mergers and acquisitions, increased investments, and collaborations with other organizations. To thrive and remain competitive in an evolving market landscape, the patient engagement solutions sector must provide cost-effective products.
Recent Developments:
In March 2025, Health Catalyst, Inc. announced the acquisition of Upfront Healthcare Services, Inc. for USD 86 million, with a possible USD 33.4 million earnout to improve its patient engagement capabilities.
In September 2024, AiCure, a prominent AI and advanced data analytics firm that monitors patient behavior and facilitates remote patient engagement in clinical trials, introduced its patient engagement platform, H.Code, at the 14th Annual DPHARM® conference.
In October 2023, ZS launched the ZAIDYN Connected Health solution, which is powered by artificial intelligence. This tool, which is part of the larger ZAIDYN platform, aids pharmaceutical companies, healthcare providers, and payers in fostering innovation, engaging with patients, and improving health outcomes through reliable insights.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Type, By Delivery Type, By Functionality, By End User |
| Regions covered | Northeast, Midwest, West, South |
| Companies Covered | Cerner Corporation (Oracle), NextGen Healthcare, Inc, Epic Systems Corporation,, LLC, McKesson Corporation, ResMed, Koninklijke Philips N.V, Klara Technologies, Inc, CPSI, Ltd, Experian Information Solutions, Inc. |
Key Topics Covered in the Report
- U.S. Patient Engagement Solutions Market Size (FY’2021-FY’2034)
- Overview of U.S. Patient Engagement Solutions Market
- Segmentation of U.S. Patient Engagement Solutions Market By Type (AI-Driven Engagement, Telehealth Solutions, Patient Portals, Remote Patient Monitoring, Population Health Management, Appointment and Medication Reminders, Others)
- Segmentation of U.S. Patient Engagement Solutions Market By Delivery (Web/Cloud-based, On-premise)
- Segmentation of U.S. Patient Engagement Solutions Market By Functionality (Enhanced Communication, Patient Education, Predictive Analytics, Streamlined Operations, Others)
- Segmentation of U.S. Patient Engagement Solutions Market By End-User (Healthcare Providers, Healthcare Payors, Pharmaceutical Companies, Pharmacy)
- Statistical Snap of U.S. Patient Engagement Solutions Market
- Expansion Analysis of U.S. Patient Engagement Solutions Market
- Problems and Obstacles in U.S. Patient Engagement Solutions Market
- Competitive Landscape in the U.S. Patient Engagement Solutions Market
- Details on Current Investment in U.S. Patient Engagement Solutions Market
- Competitive Analysis of U.S. Patient Engagement Solutions Market
- Prominent Players in the U.S. Patient Engagement Solutions Market
- SWOT Analysis of U.S. Patient Engagement Solutions Market
- U.S. Patient Engagement Solutions Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1.Introduction
1.1.Scope of the report1.2.Market segment analysis
2.Research Methodology
2.1.Research data source2.1.1.Secondary Data2.1.2.Primary Data2.1.3.SPERs internal database2.1.4.Premium insight from KOLs2.2.Market size estimation2.2.1.Top-down and Bottom-up approach2.3.Data triangulation
3.Executive Summary
4.Market Dynamics
4.1.Driver, Restraint, Opportunity and Challenges analysis4.1.1.Drivers4.1.2.Restraints4.1.3.Opportunities4.1.4.Challenges
5.Market variable and outlook
5.1.SWOT Analysis5.1.1.Strengths5.1.2.Weaknesses5.1.3.Opportunities5.1.4.Threats5.2.PESTEL Analysis5.2.1.Political Landscape5.2.2.Economic Landscape5.2.3.Social Landscape5.2.4.Technological Landscape5.2.5.Environmental Landscape5.2.6.Legal Landscape5.3.PORTER’s Five Forces5.3.1.Bargaining power of suppliers5.3.2.Bargaining power of buyers5.3.3.Threat of Substitute5.3.4.Threat of new entrant5.3.5.Competitive rivalry5.4.Heat Map Analysis
6.Competitive Landscape
6.1.U.S. Patient Engagement Solutions Market Manufacturing Base Distribution, Sales Area, Product Type6.2.Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in U.S. Patient Engagement Solutions Market
7.U.S. Patient Engagement Solutions Market, By Type (USD Million) 2021-2034
7.1.AI-Driven Engagement7.2.Telehealth Solutions7.3.Patient Portals7.4.Remote Patient Monitoring7.5.Population Health Management7.6.Appointment and Medication Reminders7.7.Others
8.U.S. Patient Engagement Solutions Market, By Delivery Type (USD Million) 2021-2034
8.1.Web/Cloud-based8.2.On-premise
9.U.S. Patient Engagement Solutions Market, By Functionality (USD Million) 2021-2034
9.1.Enhanced Communication9.2.Patient Education9.3.Predictive Analytics9.4.Streamlined Operations9.5.Others
10.U.S. Patient Engagement Solutions Market, By End User (USD Million) 2021-2034
10.1.Healthcare Providers10.1.1.Outpatient Facility10.1.2.Inpatient Facility10.2.Healthcare Payers10.2.1.Private10.2.2.Public10.3.Pharmaceutical Companies (Pharma)10.4.Pharmacy10.4.1.Independent Pharmacies (Nuclear Pharmacies)10.4.2.Community Pharmacies10.4.3.Mail-Order Pharmacies10.4.4.Retail Pharmacies10.4.5.Digital Pharmacies10.4.6.Specialty Pharmacies10.4.7.Central Fill Pharmacies10.4.8.Compounding Pharmacies10.4.9.Others
11.U.S. Patient Engagement Solutions Market, (USD Million) 2021-2034
11.1.U.S. Patient Engagement Solutions Market Size and Market Share
12.U.S. Patient Engagement Solutions Market, By Region, (USD Million) 2021-2034
12.1.Northeast12.2.Midwest12.3.West12.4.South
13.Company Profile
13.1.Cerner Corporation (Oracle)13.1.1.Company details13.1.2.Financial outlook13.1.3.Product summary13.1.4.Recent developments13.2.NextGen Healthcare, Inc13.2.1.Company details13.2.2.Financial outlook13.2.3.Product summary13.2.4.Recent developments13.3.Epic Systems Corporation13.3.1.Company details13.3.2.Financial outlook13.3.3.Product summary13.3.4.Recent developments13.4.Allscripts Healthcare, LLC13.4.1.Company details13.4.2.Financial outlook13.4.3.Product summary13.4.4.Recent developments13.5.McKesson Corporation13.5.1.Company details13.5.2.Financial outlook13.5.3.Product summary13.5.4.Recent developments13.6.ResMed13.6.1.Company details13.6.2.Financial outlook13.6.3.Product summary13.6.4.Recent developments13.7.Koninklijke Philips N.V13.7.1.Company details13.7.2.Financial outlook13.7.3.Product summary13.7.4.Recent developments13.8.Klara Technologies, Inc13.8.1.Company details13.8.2.Financial outlook13.8.3.Product summary13.8.4.Recent developments13.9.CPSI, Ltd13.9.1.Company details13.9.2.Financial outlook13.9.3.Product summary13.9.4.Recent developments13.10.Experian Information Solutions, Inc13.10.1.Company details13.10.2.Financial outlook13.10.3.Product summary13.10.4.Recent developments13.11.Others
14.Conclusion
15.List of Abbreviations
16.Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
"North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa
Companies Covered Abbvie, Galderma, Ispen, Medytox Inc., Merz GmbH and Co. KGaA, Revance Therapeutics, Inc., Sinclair Pharma."
The report includes an in-depth analysis of the Global Facial Injectable Market , including market size and trends, product mix, Applications, and supplier analysis.
U.S. Patient Engagement Solutions Market is projected to reach USD 47.86 by 2034, growing at a CAGR of 20.03% during the forecast period.
U.S. Patient Engagement Solutions Market size from 2025. The Market is expected to reach USD 47.86 by 2034, at a CAGR of 20.03% during the forecast period.
U.S. Patient Engagement Solutions Market CAGR of 20.03% during the forecast period.
You can get the sample pages by clicking the link - Click Here
U.S. Patient Engagement Solutions Market size is USD 47.86 from 2025 to 2034.
U.S. Patient Engagement Solutions Market overed By Type, By Delivery Type, By Functionality, By End User
The North America is anticipated to have the highest Market share in the U.S. Patient Engagement Solutions Market .
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
